Reports for LAMIVUDINE

Ingredient

LAMIVUDINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 300MG 150MG TABLET Actual shortage 2018-12-05 2020-06-15 68700
MYLAN-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Avoided shortage 2019-04-10 2019-05-28 81021
HEPTOVIR 5MG SOLUTION Resolved 2017-08-10 2017-09-13 18727
KIVEXA 600MG 300MG TABLET Resolved 2019-01-30 2019-03-15 74011
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
APO-LAMIVUDINE HBV 100MG TABLET Resolved 2019-12-05 2020-02-25 100278
APO-LAMIVUDINE HBV 100MG TABLET Resolved 2021-05-07 2021-06-28 138957
APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG TABLET Resolved 2017-12-06 2018-07-03 31907
MYLAN-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Resolved 2018-10-23 2019-02-16 65420
MYLAN-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Resolved 2019-05-28 2019-06-19 85021

Showing 1 to 10 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HEPTOVIR 100MG TABLET Discontinued 2022-05-13 2022-08-10 160500
HEPTOVIR 5MG SOLUTION Discontinued 2022-05-13 2022-07-22 160503
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
TRIZIVIR 300MG 300MG 150MG TABLET Discontinued 2019-09-18 2019-09-18 94278
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260

Showing 1 to 7 of 7